STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia

Keywords: TKI resistance, BCR-ABL1-independent resistance, BCR-ABL1-dependent resistance, CML stem cell, STAT3, pSTAT3[sup.Y705], BP-5-087

Saved in:
Bibliographic Details
Published inLeukemia Vol. 3; no. Suppl 1; pp. S5 - S6
Main Authors Eiring, A M, Kraft, I L, Page, B D, O'Hare, T, Gunning, P T, Deininger, M W
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2014
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Keywords: TKI resistance, BCR-ABL1-independent resistance, BCR-ABL1-dependent resistance, CML stem cell, STAT3, pSTAT3[sup.Y705], BP-5-087
AbstractList Keywords: TKI resistance, BCR-ABL1-independent resistance, BCR-ABL1-dependent resistance, CML stem cell, STAT3, pSTAT3[sup.Y705], BP-5-087
Audience Academic
Author Kraft, I L
Page, B D
Deininger, M W
Eiring, A M
O'Hare, T
Gunning, P T
Author_xml – sequence: 1
  givenname: A M
  surname: Eiring
  fullname: Eiring, A M
  organization: Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute
– sequence: 2
  givenname: I L
  surname: Kraft
  fullname: Kraft, I L
  organization: Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute
– sequence: 3
  givenname: B D
  surname: Page
  fullname: Page, B D
  organization: Department of Chemical and Physical Sciences, University of Toronto
– sequence: 4
  givenname: T
  surname: O'Hare
  fullname: O'Hare, T
  organization: Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute
– sequence: 5
  givenname: P T
  surname: Gunning
  fullname: Gunning, P T
  organization: Department of Chemical and Physical Sciences, University of Toronto
– sequence: 6
  givenname: M W
  surname: Deininger
  fullname: Deininger, M W
  email: michael.deininger@hci.utah.edu
  organization: Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27175272$$D View this record in MEDLINE/PubMed
BookMark eNptkt9r2zAQx8VoWbuuj3sdgsHYizP9sC3rZZCGbisEBl32LFTpnKizpUyyB_3vK5MuTUYlkITuc1_dne4NOvHBA0LvKJlRwpvPHYxp3M4YoeWMv0LnjJRlUTEmT_ZnSs7QZUr3JI9aClI2r9EZE1RUTLBzdPtzNV9xrBPWuAfr9BAiDi2-WtwW86slLZy3sIW8-AFHSC4N2hvAzmOzicE7g_sH6IKzOAfzG3qn36LTVncJLp_2C_Tr6_Vq8b1Y_vh2s5gvC8Ol4AXVwghZgQVLoeZCGM04r1piKW0Yb8ldWQKXRgA3gupKWMtLaWVNqZS2IfwCfdnpbse7HLrJEUbdqW10vY4PKminji3ebdQ6_FVlU1HW0Czw6Ukghj8jpEH1LhnoOu0hjElR0UjCueA8ox_-Q-_DGH1Ob6JIzURVkWdqrTtQzrchv2smUTUva0okl1RkavYClafN1TP5g1uX748cPh44bEB3wyaFbhxc8OkYLHagiSGlCO2-GJSoqWHUrmHU1DBqyur9YQX39L_2eA41ZZNfQzxI-0XFR3m0ymI
CitedBy_id crossref_primary_10_3390_cancers14143300
crossref_primary_10_1038_s41375_020_0858_1
crossref_primary_10_1007_s11427_018_9324_y
crossref_primary_10_1111_bjh_14883
crossref_primary_10_1042_BST20190223
crossref_primary_10_1016_j_beha_2020_101194
crossref_primary_10_1016_j_pharmthera_2018_06_006
crossref_primary_10_3390_pharmaceutics14010215
crossref_primary_10_1038_s41388_021_01732_6
crossref_primary_10_1016_j_coph_2020_08_006
crossref_primary_10_3324_haematol_2019_232793
crossref_primary_10_1016_j_hoc_2017_04_007
crossref_primary_10_1016_j_molmet_2021_101410
crossref_primary_10_3389_fimmu_2018_00481
crossref_primary_10_1016_j_bcp_2021_114658
crossref_primary_10_1038_s41375_020_01037_9
Cites_doi 10.1126/science.1062538
10.1016/S1535-6108(02)00096-X
10.1182/blood-2012-02-412890
10.1186/1756-8722-4-6
10.1158/0008-5472.CAN-12-3955
10.1158/1535-7163.MCT-08-0314
10.1182/blood.V99.1.319
10.1172/JCI35721
ContentType Journal Article
Copyright Macmillan Publishers Limited 2014
COPYRIGHT 2014 Nature Publishing Group
Copyright Nature Publishing Group Dec 2014
Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited
Copyright_xml – notice: Macmillan Publishers Limited 2014
– notice: COPYRIGHT 2014 Nature Publishing Group
– notice: Copyright Nature Publishing Group Dec 2014
– notice: Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/leusup.2014.3
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate STAT3-mediated drug resistance in CML
EISSN 2044-5229
1476-5551
EndPage S6
ExternalDocumentID 4020562111
A461093917
10_1038_leusup_2014_3
27175272
Genre Journal Article
GroupedDBID 3V.
4.4
7X7
8FI
8FJ
AAZLF
ABJNI
ABUWG
ACGFS
ADBBV
AFKRA
AFSHS
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
EE.
EJD
FYUFA
HMCUK
HYE
OK1
PQQKQ
PROAC
RNT
RNTTT
RPM
SNYQT
TAOOD
TBHMF
TDRGL
UKHRP
NPM
AAYXX
CITATION
---
-Q-
.XZ
0R~
29L
2WC
36B
39C
406
53G
5GY
5RE
70F
7RV
88E
8AO
8C1
8R4
8R5
AANZL
AASDW
AATNV
AAWBL
AAWTL
ABAKF
ABAWZ
ABDBF
ABLJU
ABOCM
ABZZP
ACAOD
ACGFO
ACKTT
ACMJI
ACPRK
ACRQY
ACZOJ
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFRAH
AGAYW
AGEZK
AGHAI
AGQEE
AHSBF
AILAN
AJRNO
ALFFA
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BBNVY
BHPHI
BKEYQ
BKKNO
CS3
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EBC
EBD
EBLON
EBX
EIOEI
EMB
EMK
EMOBN
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIZPM
FSGXE
HCIFZ
HVGLF
HZ~
IAO
IH2
IHR
IHW
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M7P
N9A
NAO
NAPCQ
NQJWS
NXXTH
O9-
OVD
P2P
PSQYO
Q2X
SNX
SOHCF
SRMVM
SV3
SWTZT
TEORI
TSG
TUS
WOW
~8M
AADWK
AAYFA
AAYJO
ABGIJ
ACBMV
ACBRV
ACBYP
ACIGE
ACTTH
ACVWB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AFNRJ
AGGBP
AHGBK
AJCLW
AJDOV
AMRJV
NYICJ
ZA5
FIGPU
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c3973-1a7c795eded1e6377ca2335f0d11823f0b44e39c7e3c71a57dd349d961199d803
IEDL.DBID RPM
ISSN 2044-5210
0887-6924
IngestDate Tue Sep 17 21:08:08 EDT 2024
Fri Jun 28 12:50:20 EDT 2024
Thu Oct 10 16:34:34 EDT 2024
Thu Feb 22 23:38:19 EST 2024
Fri Feb 02 04:29:33 EST 2024
Tue Aug 20 22:13:36 EDT 2024
Fri Aug 23 03:33:39 EDT 2024
Sat Sep 28 08:06:39 EDT 2024
Fri Oct 11 20:50:49 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Suppl 1
Keywords CML stem cell
BP-5-087
BCR-ABL1-independent resistance
STAT3
BCR-ABL1-dependent resistance
pSTAT3
TKI resistance
pSTAT3Y705
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3973-1a7c795eded1e6377ca2335f0d11823f0b44e39c7e3c71a57dd349d961199d803
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://europepmc.org/articles/pmc4851281?pdf=render
PMID 27175272
PQID 1780627550
PQPubID 2041948
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4851281
proquest_miscellaneous_1789033733
proquest_journals_1780627550
gale_infotracmisc_A461093917
gale_infotracacademiconefile_A461093917
gale_healthsolutions_A461093917
crossref_primary_10_1038_leusup_2014_3
pubmed_primary_27175272
springer_journals_10_1038_leusup_2014_3
PublicationCentury 2000
PublicationDate 20141201
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 20141201
  day: 1
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Leukemia
PublicationTitleAbbrev Leukemia Suppl
PublicationTitleAlternate Leuk Suppl
PublicationYear 2014
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Corbin, Agarwal, Loriaux, Cortes, Deininger, Druker (CR8) 2011; 121
Gorre, Mohammed, Ellwood, Hsu, Paquette, Rao (CR1) 2001; 293
Zhang, Li, McDonald, Holyoake, Moon, Campana (CR4) 2013; 121
Quentmeier, Eberth, Romani, Zaborski, Drexler (CR6) 2011; 4
Bewry, Nair, Emmons, Boulware, Pinilla-Ibarz, Hazlehurst (CR3) 2008; 7
Shah, Nicoll, Nagar, Gorre, Paquette, Kuriyan (CR2) 2002; 2
Graham, Jorgensen, Allan, Pearson, Alcorn, Richmond (CR7) 2002; 99
Casetti, Martin-Lanneree, Najjar, Plo, Auge, Roy (CR5) 2013; 73
23400594 - Cancer Res. 2013 Apr 1;73(7):2052-8
11423618 - Science. 2001 Aug 3;293(5531):876-80
12204532 - Cancer Cell. 2002 Aug;2(2):117-25
23299311 - Blood. 2013 Mar 7;121(10):1824-38
18852120 - Mol Cancer Ther. 2008 Oct;7(10):3169-75
21157039 - J Clin Invest. 2011 Jan;121(1):396-409
21299849 - J Hematol Oncol. 2011 Feb 07;4:6
11756187 - Blood. 2002 Jan 1;99(1):319-25
B Zhang (BFleusup20143_CR4) 2013; 121
AS Corbin (BFleusup20143_CR8) 2011; 121
NN Bewry (BFleusup20143_CR3) 2008; 7
H Quentmeier (BFleusup20143_CR6) 2011; 4
SM Graham (BFleusup20143_CR7) 2002; 99
NP Shah (BFleusup20143_CR2) 2002; 2
L Casetti (BFleusup20143_CR5) 2013; 73
ME Gorre (BFleusup20143_CR1) 2001; 293
References_xml – volume: 293
  start-page: 876
  year: 2001
  end-page: 880
  ident: CR1
  article-title: Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
  publication-title: Science
  doi: 10.1126/science.1062538
  contributor:
    fullname: Rao
– volume: 2
  start-page: 117
  year: 2002
  end-page: 125
  ident: CR2
  article-title: Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(02)00096-X
  contributor:
    fullname: Kuriyan
– volume: 121
  start-page: 1824
  year: 2013
  end-page: 1838
  ident: CR4
  article-title: Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling
  publication-title: Blood
  doi: 10.1182/blood-2012-02-412890
  contributor:
    fullname: Campana
– volume: 4
  start-page: 6
  year: 2011
  ident: CR6
  article-title: BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-4-6
  contributor:
    fullname: Drexler
– volume: 73
  start-page: 2052
  year: 2013
  end-page: 2058
  ident: CR5
  article-title: Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-3955
  contributor:
    fullname: Roy
– volume: 7
  start-page: 3169
  year: 2008
  end-page: 3175
  ident: CR3
  article-title: Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-08-0314
  contributor:
    fullname: Hazlehurst
– volume: 99
  start-page: 319
  year: 2002
  end-page: 325
  ident: CR7
  article-title: Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571
  publication-title: Blood
  doi: 10.1182/blood.V99.1.319
  contributor:
    fullname: Richmond
– volume: 121
  start-page: 396
  year: 2011
  end-page: 409
  ident: CR8
  article-title: Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
  publication-title: J Clin Invest
  doi: 10.1172/JCI35721
  contributor:
    fullname: Druker
– volume: 7
  start-page: 3169
  year: 2008
  ident: BFleusup20143_CR3
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-08-0314
  contributor:
    fullname: NN Bewry
– volume: 121
  start-page: 1824
  year: 2013
  ident: BFleusup20143_CR4
  publication-title: Blood
  doi: 10.1182/blood-2012-02-412890
  contributor:
    fullname: B Zhang
– volume: 2
  start-page: 117
  year: 2002
  ident: BFleusup20143_CR2
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(02)00096-X
  contributor:
    fullname: NP Shah
– volume: 121
  start-page: 396
  year: 2011
  ident: BFleusup20143_CR8
  publication-title: J Clin Invest
  doi: 10.1172/JCI35721
  contributor:
    fullname: AS Corbin
– volume: 99
  start-page: 319
  year: 2002
  ident: BFleusup20143_CR7
  publication-title: Blood
  doi: 10.1182/blood.V99.1.319
  contributor:
    fullname: SM Graham
– volume: 293
  start-page: 876
  year: 2001
  ident: BFleusup20143_CR1
  publication-title: Science
  doi: 10.1126/science.1062538
  contributor:
    fullname: ME Gorre
– volume: 4
  start-page: 6
  year: 2011
  ident: BFleusup20143_CR6
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-4-6
  contributor:
    fullname: H Quentmeier
– volume: 73
  start-page: 2052
  year: 2013
  ident: BFleusup20143_CR5
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-3955
  contributor:
    fullname: L Casetti
SSID ssj0000697048
ssj0014766
Score 2.1714208
Snippet Keywords: TKI resistance, BCR-ABL1-independent resistance, BCR-ABL1-dependent resistance, CML stem cell, STAT3, pSTAT3[sup.Y705], BP-5-087
SourceID pubmedcentral
proquest
gale
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage S5
SubjectTerms 631/80/86
692/699/67/1059/2326
692/699/67/1990/283/1896
Cancer Research
Cell differentiation
Chronic myeloid leukemia
Critical Care Medicine
Hematology
Intensive
Internal Medicine
Medicine & Public Health
Oncology
Special Report
Stem cells
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLggEK-lpTUSgpOpnXHi-FRtK6oKtRzKVtqb5dheEdEmLbt74N8zdrJps0KcPZbsedjf-PENIR8lVCCE80zaomCx1D2zCCRYhb6ibQaFTmU6L74XZ1fy2zyf9wduy_5Z5WZNTAu1b108Iz8UqkyMujk_ur1jsWpUvF3tS2g8Jk9EhmAC_VnN1XDGwguteCqglXEpMecSvKfZ5FAeXof1ch0pK4X8AqNtaXtxfrA7bb-c3Lo-TbvS6XPyrIeTdNrZ_wV5FJqX5PLHbDoDapfU0vQzBPNq2i7o8cklmx6fC1YPtW9XFNPtCCHR9rRuqOu4cunNn3Dd1p7i6H-Fm9q-IlenX2cnZ6yvncAcIgxgwiqndB588CIUoJRDxUO-4D5mFLDglZQBtFMBnBI2V96D1F4XQmjtSw6vyU7TNuEtoRUmrB5xko1wy-uqwgwF7bjAxcEWQWcT8mmjOnPbUWSYdLUNpel0bKKODUzIQVSs6X54DqFlponzHTBxnJDPSSIGF-rX2f6PAA4k0lSNJPdGkhgUbty8MZ7pg3Jp7l1oQj4MzbFnfGjWhHadZDQHUICjfdPZephUhqlvnimcsBp5wSAQqbrHLU39M1F2SwS2WSlwfht_eTCsf-nq3f8nsEueRrnuXc0e2Vn9Xof3iI5W1X4Kgb-l5wtV
  priority: 102
  providerName: ProQuest
Title STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia
URI https://link.springer.com/article/10.1038/leusup.2014.3
https://www.ncbi.nlm.nih.gov/pubmed/27175272
https://www.proquest.com/docview/1780627550
https://search.proquest.com/docview/1789033733
https://pubmed.ncbi.nlm.nih.gov/PMC4851281
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBba7rLLsGIvb12mAsN2cmKZsmUdk6BFMbRFkaVAboYsKZixxCmW5LB_P0p-IA562lm0LVGkxA8mPxLylUMBjGkTcpWmoWt1HyoMJMICbUWqGFLp23Te3ac3j_zHIlmckKSthfFJ-7ooh9VqPazKXz638mmtR22e2OjhbsoxTIgzNjolpwLgAKLXx68Uke-aFUecI9BiUcOtGUE2Wtn9du94Khkfuh46McKZJBZx71o6PpwPbqfjzMmj36f-Vrp-TV414SQd19M-Jye2ekNmP-fjOVC1pYr6yhDE1XSzpJPpLBxPbllYdr1vdxThtgshce9pWVFdc-XS9V-72pSG4kJ-23Wp3pLH66v59CZseieEGiMMCJkSWsjEGmuYTUEIjYqHZBkZhyhgGRWcW5BaWNCCqUQYA1wamTImpckieEfOqk1lPxBaIGA1GCcpF24ZWRSIUHAfl3g4qNTKOCDfWtXlTzVFRu5_bUOW1-rOnbpzCMgXp9i8rvDsXCsfe853QOAYkO9ewjkX6lerpkYAJ-JoqnqSFz1JdArdH243L2-ccpszkXlS5iQKyGU37J50iWaV3ey9jIwA0KwC8r7e625Rra0ERPSsoBNwVN39EbRgT9ndWCyur7WXg2k9p6uP__2NT-Sle0WdcnNBznZ_9vYzBk67YoDushAD8mJydf8wG3i3-QfBJBbO
link.rule.ids 230,315,733,786,790,891,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,74100,74657
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagHOCCQLwChRoJwcnU3vGu1yeUVlQB0h5KKuVmeW1HXdFuCkkO_HvG3s3SjRBnjyXP0zN-fEPIOwkVCOE8k7YoWGx1zywmEqxCW9E2g0KnNp2nZ8XkQn6d5_PuwG3VPavcxsQUqP3SxTPyQ6HKhKib8083P1nsGhVvV7sWGnfJPQkgo52ruerPWHihFU8NtDIuJdZcgncwmxzKw6uwWW0iZKWQH2GwLe0G51u70-7LyZ3r07QrnTwiD7t0ko5b_T8md0LzhJx_n41nQO2KWpp-hmBdTZcLenR8zsZHU8HqvvftmmK5HVNI1D2tG-parFx6_TtcLWtPcfU_wnVtn5KLk8-z4wnreicwhxkGMGGVUzoPPngRClDKoeAhX3AfKwpY8ErKANqpAE4JmyvvQWqvCyG09iWHZ2SvWTbhBaEVFqwe8yQb0y2vqworFNTjAoODLYLORuT9VnTmpoXIMOlqG0rTythEGRsYkYMoWNP-8Oxdy4wT5jtg4TgiHxJFdC6Ur7PdHwFcSISpGlDuDyjRKdxweKs80znlyvw1oRF52w_HmfGhWROWm0SjOYACXO3zVtc9UxmWvnmmkGE1sIKeIEJ1D0ea-jJBdktMbLNSIH9be7m1rH_J6uX_GTgg9yez06mZfjn79oo8iHPaNzb7ZG_9axNeY6a0rt4kd_gDWVsOQg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI9gSIgXBOLrYLAgIXgKl9Rp0zyh2-A0YExo3KR7q9IkFRVbO7i7B_57nLRX1hPiOY4UO3ZsJ87PhLySUIIQ1jFpsoyFVvfMYCDBStQVbRLIdGzT-eU0Oz6Xn5bpsq9_WvVlldszMR7UrrXhjnwqVB4RdVM-rfqyiK_v5--ufrLQQSq8tPbtNG6SW-gleWjjoJZquG_hmVY8NtNKuJSYfwneQ25yyKcXfrPaBPhKId_CyEXtHtTXPNVuFeXOU2r0UPN75G4fWtJZpwv3yQ3fPCBn3xazBVCzoobGXyKYY9O2oodHZ2x2eCJYPfTBXVNMvUM4iXpA64baDjeXXv72F23tKK7-h7-szUNyPv-wODpmfR8FZjHaACaMskqn3nknfAZKWdwESCvuQnYBFS-l9KCt8mCVMKlyDqR2OhNCa5dzeET2mrbxTwgtMXl1GDOZEHo5XZaYreCeVnhQmMzrZEJeb0VXXHVwGUV85oa86GRcBBkXMCEHQbBF99tzMLNiFvHfAZPICXkTKYKhoXyt6f8L4EICZNWIcn9EiQZix8PbzSt6A10Vf9VpQl4Ow2FmKDprfLuJNJoDKMDVPu72emAqwTQ4TRQyrEZaMBAE2O7xSFN_j_DdEoPcJBfI31Zfri3rX7J6-n8GDshttITi5OPp52fkTpjSldvsk731r41_jkHTunwRreEPEMASbg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=STAT3+as+a+mediator+of+BCR-ABL1-independent+resistance+in+chronic+myeloid+leukemia&rft.jtitle=Leukemia+supplements&rft.au=Eiring%2C+A+M&rft.au=Kraft%2C+I+L&rft.au=Page%2C+B+D&rft.au=O%27Hare%2C+T&rft.date=2014-12-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=2044-5210&rft.eissn=2044-5229&rft.volume=3&rft.issue=Suppl+1&rft.spage=S5&rft.epage=S6&rft_id=info:doi/10.1038%2Fleusup.2014.3&rft.externalDocID=10_1038_leusup_2014_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-5210&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-5210&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-5210&client=summon